Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alembic Ltd Interim / Quarterly Report 2026

May 19, 2026

61312_rns_2026-05-19_bf709830-ad7f-4f0d-94b1-fe0c1489c70c.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Alembic Touching Lives over 100

Date: 19th May, 2026

To,

The Manager,

Department of Corporate Services,

BSE Limited

1st Floor, Phiroze Jeejeebhoy Towers,

Dalal Street, Fort,

Mumbai - 400 001

Scrip Code: 506235

To,

The Manager,

Listing Department,

National Stock Exchange of India Limited

“Exchange Plaza”

Bandra Kurla Complex, Bandra (E),

Mumbai – 400 051

NSE Symbol: ALEMBICLTD

Dear Sir,

Sub: Outcome of Board Meeting

With reference to the captioned subject, the exchanges are hereby informed that the Board of Directors of Alembic Limited at its meeting held today has inter alia:

  1. Approved the Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2026.

In this regard, we enclose the following:

a) Consolidated Audited Financial Results for the quarter and financial year ended 31st March, 2026 along with Auditors Report.

b) Standalone Audited Financial Results for the quarter and financial year ended 31st March, 2026 along with Auditors Report.

We hereby confirm and declare that the Statutory Auditors of the Company M/s. CNK & Associates LLP (FRN:101961W/W-100036), have issued an Audit Report on the Consolidated and Standalone Audited Financial Results of the Company for the year ended 31st March, 2026, with unmodified opinion. This declaration is given in compliance Regulations 33(3)(d) of the SEBI Listing Obligations and Disclosure Requirement) Regulations, 2015.

  1. Recommended Dividend of Rs. 2.40 (120%) per Equity Share having face value of Rs. 2/- each for the year ended 31st March, 2026, subject to approval of Shareholders at the ensuing Annual General Meeting.

img-0.jpeg

ALEMBIC LIMITED

REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. • TEL: (0265) 6637000

website: www.alembiclimited.com • E-mail: [email protected] • CIN: L26100GJ1907PLC000033


Alembic Touching Lives over 100

The time of commencement of the Board Meeting was 4:30 p.m. and the time of conclusion was 5:45 p.m.

We request you to kindly take the same on record.

Thanking you,

Yours faithfully,

For Alembic Limited

img-1.jpeg

img-2.jpeg

Encl.: A/a

ALEMBIC LIMITED

REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. • TEL: (0265) 6637000

website: www.alembiclimited.com • E-mail: [email protected] • CIN: L26100GJ1907PLC000033


Alembic

ALEMBIC LIMITED
C/N:L26100GJ1907PLC000033
Regd. Office: Alembic Road, Vadodara 390 003
Ph:0265 6637000
www.alembiclimited.com Email:[email protected]

Statement of Consolidated Audited Financial Results for the Quarter and Year ended 31st March, 2026
Rs. in Lakhs

Sr. No Particulars Quarter Ended Year Ended
31.3.2026 (Audited) 31.12.2025 (Unaudited) 31.3.2025 (Audited) 31.3.2026 (Audited) 31.03.2025 (Audited)
1 Revenue from Operations 6,004 7,434 6,027 23,999 22,189
2 Other Income 214 231 296 7,297 7,489
3 Total Income 6,218 7,665 6,323 31,296 29,678
4 Expenses
Cost of Materials Consumed 404 385 192 1,388 800
Cost of Construction 1,463 2,238 1,549 6,002 6,005
Changes in Inventories of Finished Goods and WIP (65) 105 (3) 255 111
Employee Benefit Expenses 1,174 1,032 650 3,744 2,731
Finance Costs 57 55 62 228 247
Depreciation and amortisation expense 334 344 275 1,239 1,063
Other Expenses 1,006 930 906 3,564 3,170
Total Expenses 4,374 5,089 3,632 16,420 14,128
5 Profit Before Tax (3-4) 1,844 2,576 2,692 14,876 15,550
6 Tax Expenses
Current Tax 566 390 345 2,263 1,763
Deferred Tax 287 (61) 128 (10) (514)
Short / (Excess) Provision of earlier years 30 - (156) 30 (156)
7 Net Profit after tax for the Period 961 2,247 2,375 12,593 14,457
8 Share of Associate's Profit/(Loss) 5,752 3,766 4,470 19,145 16,610
9 Net Profit/(Loss) after tax and Share of Associate's Profit/(Loss) 6,713 6,013 6,845 31,738 31,068
10 Other Comprehensive Income
A (i) Items that will not be reclassified to Profit or (Loss) (11,724) (13,653) (2,626) (10,562) (3,511)
(ii) Income tax relating to items that will not be reclassified to Profit or (Loss) 1,241 1,792 388 925 (108)
B (i) Items that will be reclassified to Profit or (Loss) 384 164 106 882 188
11 Total Comprehensive Income/(Loss) for the Period (3,387) (5,684) 4,713 22,983 27,636
12 Paid up Equity Share Capital (Face Value of Rs 2/- per share) 5,135.64 5,135.64 5,135.64 5,135.64 5,135.64
13 Other Equity (excluding Revaluation Reserve) 2,24,927 2,04,790
14 Earnings per equity share (FV Rs. 2/- per share) 2.61 2.34 2.67 12.36 12.10
Basic & Diluted (In Rs.)

ALEMBIC LIMITED
ALEMBIC GUIDE
VADODARA


Alembic Limited

Segment wise Consolidated Revenue and Results

Rs. In Lakhs

r.No Particulars Quarter Ended Year Ended
31.3.2026 (Audited) 31.12.2025 (Unaudited) 31.3.2025 (Audited) 31.3.2026 (Audited) 31.03.2025 (Audited)
1 Segment Revenue
Revenue from Operations
a. Active Pharmaceutical Ingredients Business 983 1,350 778 4,659 3,221
b. Real Estate Business 5,021 4,556 5,248 19,340 18,967
Total Income from Operations (Net) 6,004 7,434 6,027 23,999 22,189
2 Segment Results (Profit (+)/ Loss (-) before Taxes and interest from each segment)
a. Active Pharmaceutical Ingredients Business (117) 214 188 565 473
b. Real Estate Business 2,097 2,385 2,563 8,117 8,806
Total 1,980 2,599 2,751 8,682 9,278
Unallocable Income and Expenditure
(i) Interest Expense (57) (55) (62) (228) (247)
(ii) Dividend Income and Gain/(Loss) on Fair Value Change of Financial Asset (121) 18 (12) 6,167 6,471
(iii) Other Income / (Expense) 42 14 15 255 47
Total Profit Before Tax 1,844 2,576 2,692 14,876 15,550
3 Segment Assets
a. Active Pharmaceutical Ingredients Business 18,081 18,400 18,722 18,081 18,722
b. Real Estate Business 51,578 48,918 44,313 51,578 44,313
c. Unallocated 1,89,291 1,95,743 1,87,265 1,89,291 1,87,265
Total 2,58,951 2,63,061 2,50,300 2,58,951 2,50,300
4 Segment Liabilities
a. Active Pharmaceutical Ingredients Business 3,480 3,350 3,128 3,480 3,128
b. Real Estate Business 8,148 8,060 9,947 8,148 9,947
c. Unallocated 2,814 3,754 3,367 2,814 3,367
Total 14,442 15,165 16,441 14,442 16,441

Notes:

1 The above results have been audited by Statutory Auditors, recommended by Audit Committee and approved by the Board of Directors of the Company.
2 The Board has recommended Dividend on equity shares at Rs 2.40 per share (face value Rs. 2/- each) i.e 120% for the year ended on 31st March, 2026 (Previous year Rs. 2.40 per share i.e 120%).
3 The previous quarter's / year's figures have been regrouped / rearranged wherever necessary to make it comparable with the current quarter / year.
4 The figures for the quarter ended 31st March, 2026 and corresponding quarter ended 31st March, 2025 are the balancing figures between the audited figures in respect of full financial year and year to date figures upto third quarter of the respective financial years which were subject to limited review.
5 The Government of India has notified the implementation of four new Labour Codes effective 21st November, 2025, by consolidating and rationalizing 29 existing labour laws. The Company has provisionally estimated the financial implications thereof and has made additional provision under 'Employee Benefit Expense' for Rs. 143.72 lakh in the financial results for the quarter ended on 31st December, 2025. This will be reviewed and revised, if required once all applicable Rules are notified by the Government on all aspects of the Codes.

Place : Vadodara

Date : 19th May, 2026

img-3.jpeg

img-4.jpeg

img-5.jpeg


R5. in Lakhs

Alembic Limited

Statement of Consolidated Assets and Liabilities

Particulars As at 31st March, 2026 (Audited) As at 31st March, 2025 (Audited)
ASSETS
Non-Current Assets
(a) Property, Plant and Equipments 16,995 13,533
(b) Capital Work-in-Progress 150 -
(c) Investment Property 30,171 27,357
(d) Goodwill 5 5
(e) Financial Assets
(i) Investments 17,310 27,736
(ii) Investments accounted using Equity Method 1,70,443 1,56,759
(iii) Others 652 923
(f) Other Non-Current Assets 3,500 3,500
2,39,227 2,29,814
Current Assets
(a) Inventories 5,224 9,939
(b) Financial Assets
(i) Investments 9,662 5,510
(ii) Trade Receivables 3,190 2,997
(iii) Cash and Cash Equivalents 141 271
(iv) Bank Balances other than Cash and Cash Equivalents 187 166
(v) Others 353 319
(c) Other Current Assets 966 1,286
19,724 20,487
TOTAL - ASSETS 2,58,951 2,50,300
EQUITY AND LIABILITIES
Equity
(a) Equity Share Capital 5,136 5,136
(b) Other Equity 2,39,373 2,28,723
2,44,509 2,33,859
Liabilities
Non-Current Liabilities
(a) Financial Liabilities
(i) Borrowings 661 1,067
(ii) Other Financial Liabilities 1,350 1,247
(b) Provisions 372 244
(c) Deferred Tax Liability (Net) 1,929 2,837
4,312 5,394
Current Liabilities
(a) Financial Liabilities
(i) Borrowings 403 378
(ii) Trade Payables
a) total outstanding dues of Micro and Small Enterprises 687 533
b) total outstanding dues of Others 1,698 2,293
(iii) Other Financial Liabilities 1,168 789
(b) Other Current Liabilities 3,010 4,372
(c) Provisions 2,280 2,152
(d) Current Tax Liabilities (Net) 885 530
10,130 11,047
TOTAL - EQUITY AND LIABILITIES 2,58,951 2,50,300

For Alembic Limited

Place : Vadodara

Date : 19th May, 2026

VADODARA

Vasudevan

Chirayu Amin

Chairman


Alembic Limited

Consolidated Statement of Cash Flow for Year ended 31st March,2026

Rs. In Lakhs

Particulars For the Year Ended on 31st March, 2026 (Audited) For the Year Ended on 31st March, 2025 (Audited)
A CASH FLOW FROM OPERATING ACTIVITIES:
Net Profit before tax 14,876 15,550
Add:
Depreciation 1,239 1,063
Interest charged 228 247
(Gain) / Loss on sale of Property, Plant and Equipments - 105
Other Non cash items 31 (213)
Less:
Interest Income (156) (204)
Dividend Income (6,295) (6,295)
Operating Profit before change in working capital 9,922 10,252
Working capital changes:
Add / (Less):
(Increase) / Decrease in Inventories 4,715 (678)
(Increase) / Decrease in Trade Receivables (193) (1,021)
(Increase) / Decrease in Other Assets 320 (430)
(Increase) / Decrease in Financial Assets 237 211
Increase / (Decrease) in Trade Payables (442) (276)
Increase / (Decrease) in Financial Liabilities 462 210
Increase / (Decrease) in Other Liabilities (1,362) 1,878
Increase / (Decrease) in Provisions 286 47
Cash generated from operations 13,944 10,193
Add / (Less):
Direct taxes paid (Net of refunds) (1,938) (1,556)
Net cash inflow from operating activities (A) 12,007 8,637
B CASH FLOW FROM INVESTING ACTIVITIES:
Add:
Proceeds from sale of Property, Plant and Equipments - 0
Proceeds from sale / redemption of Investments 12,978 11,721
Interest received 156 204
Dividend received 6,295 6,295
Less: 19,430 18,220
Purchase of PPE and Investment Property/Increase in CWIP and Capital Advances 7,665 5,077
Purchase of Investments 17,129 15,756
Increase in Restricted Bank Balances other than Cash & Cash Equivalents 21 45
24,816 20,878
Net cash inflow from Investing activities (B) (5,386) (2,658)
C CASH FLOW FROM FINANCING ACTIVITIES:
Add:
Proceeds from long term borrowings - 530
Less:
Dividends paid 6,141 6,117
Interest and other finance costs 228 247
Repayment of borrowings 381 -
6,750 6,364
Net cash inflow from Financing activities (C) (6,750) (5,834)
I. Net (Decrease) / Increase in cash and cash equivalents (A+B+C) (130) 145
II. Cash and cash equivalents at the beginning of the period 271 126
III. Cash and cash equivalents at the end of the period (I+II) 141 271
IV. Cash and cash equivalents at the end of the period
Balances with Bank 141 270
Cash on Hand 0 1
Cash and cash equivalents 141 271

For Alembic Limited

Place : Vadodara
Date : 19th May, 2026

img-6.jpeg
img-7.jpeg
img-8.jpeg
Chirayu Amin
Chairman


CNK & Associates LLP
Chartered Accountants

Independent Auditor's Report on the consolidated financial results of Alembic Limited pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended.

TO THE BOARD OF DIRECTORS OF ALEMBIC LIMITED

Report on the Audit of Consolidated Financial Results

Opinion

We have audited the accompanying statement of consolidated financial results of Alembic Limited (hereinafter referred to as the “Holding Company”) and its subsidiary (Holding Company and its subsidiary together referred to as “the Group”), and its share of the net profit after tax and total comprehensive income of its associate for the quarter and year ended 31st March, 2026, attached herewith, being submitted by the Holding Company pursuant to the requirement of Regulation 33 of the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘Listing Regulations’).

In our opinion and to the best of our information and according to the explanations given to us and based on the consideration of reports of other auditors on separate audited financial statements /financial results/ financial information of the subsidiary and associate, the aforesaid consolidated financial results:

a. includes results of the following entities:

(i) Alembic City Limited (Subsidiary)
(ii) Alembic Pharmaceuticals Limited (Associate)

b. are presented in accordance with the requirements of Regulation 33 of the Listing Regulations in this regard;

c. give a true and fair view in conformity with applicable accounting standards, and other accounting principles generally accepted in India, of the consolidated net profit and other comprehensive income and other financial information of the Group and associate for the year ended 31st March, 2026.

The Nirajand Pines, 16, Wimward Business Park, Behind Emerald One Complex, In the lane of Dr. Prasant Buch’s Hospital, Jetalpur, Vadodara 590 007. Tel: +91 265 234 3483
Website: www.cnkindia.com
VADODARA | MUMBAI | CHENNAI | AHMEDABAD | GIFT CITY | GURGOON | KOLKATA | BENGALURU | DELHI | PUNE | DUBAI | ABU DHABI


Basis of Opinion

We conducted our audit in accordance with the Standards on Auditing (SAs) specified under section 143(10) of the Companies Act, 2013, as amended ("Act"). Our responsibilities under those SAs are further described in the Auditor's Responsibilities for the Audit of the Consolidated Financial Results section of our report. We are independent of the Group and its associate in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Companies Act, 2013 and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence obtained by us and other auditors in terms of their reports referred to in "Other Matter" paragraph below, is sufficient and appropriate to provide a basis for our opinion.

Emphasis of Matter

We draw attention to the status of disputed liability related to pending electricity duty matter. During the previous periods, the Company had made aggregate provision towards total principal amount being Rs. 2,052.13 lakhs for the disputed matter(s) filed against State of Gujarat, Collector of Electricity Duty & others. The interest amount thereon is not ascertainable and is disclosed as contingent liability in the consolidated Financial Statements for the year ended 31st March, 2026. Further, the Company has deposited Rs. 3,500.00 lakhs with the Hon'ble Supreme Court on 26th May, 2023 and the appeal filed by the Company has been admitted.

Our opinion is not modified in respect of above matter.

Management's and Board of Directors' Responsibilities for the Consolidated Annual Financial Results

These consolidated financial results have been prepared on the basis of the consolidated financial statements. The Holding Company's Management and the Board of Directors are responsible for the preparation and presentation of these consolidated financial results that give a true and fair view of the consolidated net profit and other comprehensive income and other financial information of the Group including its associate in accordance with applicable accounting Standards prescribed under Section 133 of the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The respective Management and Board of Directors of the companies included in the Group and of its associate are responsible for maintenance of adequate accounting records in accordance with the

S


provisions of the Act for safeguarding of the assets of the Group and its associate and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring accuracy and completeness of the accounting records, relevant to the preparation and presentation of the consolidated financial results that give a true and fair view and are free from material misstatement, whether due to fraud or error, which have been used for the purpose of preparation of the consolidated financial results by the management and Board of the Directors of the Holding Company, as aforesaid.

In preparing the consolidated financial results, the respective Management and the Board of Directors of the companies included in the Group and of its associate are responsible for assessing the ability of the Group and its associate to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the respective Board of Directors either intends to liquidate the Group or to cease operations, or has no realistic alternative but to do so.

The respective Board of Directors of the companies included in the Group and of its associate are responsible for overseeing the financial reporting process of the Group and of its associate.

Auditor’s Responsibilities for the Audit of the Consolidated Financial Results

Our objectives are to obtain reasonable assurance about whether the consolidated financial results as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial results.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

  • Identify and assess the risks of material misstatement of the consolidated financial results, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material

SAN FRANCISCO, CALIF. VADODARA


misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

  • Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under Section 143(3) (i) of the Act, we are also responsible for expressing our opinion through a separate report on the complete set of financial statements on whether the company has adequate internal financial controls with reference to financial statements in place and the operating effectiveness of such controls.

  • Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the management and Board of Directors.

  • Conclude on the appropriateness of the Management and Board of Directors use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the ability of the Group and its associate to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the consolidated financial results or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Group and its associate to cease to continue as a going concern.

  • Evaluate the overall presentation, structure and content of the consolidated financial results, including the disclosures, and whether the consolidated financial results represent the underlying transactions and events in a manner that achieves fair presentation.

  • Obtain sufficient appropriate audit evidence regarding the financial results/financial information of the Group and its associate to express an opinion on Consolidated Financial Results. We are responsible for the direction, supervision and performance of the audit of financial information of such entities included in the consolidated financial results of which we are the independent auditors. For the other entities included in the Consolidated Financial Results, which have been audited by other auditors, such other auditors remain responsible for the direction, supervision and performance of the audits carried out by them. We remain solely responsible for our audit opinion.

VADODARA


We communicate with those charged with governance of the Holding Company and such other entities included in the consolidated financial results of which we are the independent auditors regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

We also performed procedures in accordance with the circular No CIR/CFD/CMD1/44/2019 issued by the Securities and Exchange Board of India under Regulation 33(8) of the Listing Regulations, to the extent applicable.

Other Matters

  1. The accompanying consolidated financial results include audited Financial Statements of one subsidiary which reflect total assets (before consolidation adjustment) of Rs. 17,418.80 lakhs as at 31st March, 2026, total revenues (before consolidation adjustment) of Rs. 1,176.06 lakhs and Rs. 4,070.97 lakhs, total loss after tax (before consolidation adjustment) of Rs. 127.56 lakhs and Rs. 214.52 lakhs, total comprehensive loss (before consolidation adjustment) of Rs. 127.89 lakhs and Rs. 214.89 lakhs for the quarter ended and year then ended respectively and net cash Inflow (before consolidation adjustment) of Rs. 13.29 lakhs for the year then ended, which have been audited by other auditor whose financial statements, other financial information and auditor’s report have been furnished to us by the management. Our opinion on the consolidated financial statements, in so far as it relates to the amounts and disclosures included in respect of this subsidiary is based solely on the report of such other auditor.

  2. The accompanying consolidated financial results include the Group’s share of Total Comprehensive Income (comprising of net profit after tax and other comprehensive income) of Rs. 6,081.14 lakhs and Rs. 19,854.44 lakhs for the quarter and year ended on that date, in respect of one associate, which have been audited by other auditor, whose financial statements, other financial information and auditor’s report have been furnished to us by the management. Our opinion on the consolidated financial statements, in so far as it relates to the amounts and disclosures included in respect of this associate is based solely on the report of such other auditor.

SINDAC 1954 INDOOR ASSOCIATION


Our opinion on the Consolidated Financial Results is not modified in respect of the above matters with respect to our reliance on the work done and the reports of the other auditors and the Financial Results/financial information certified by the Board of Directors.

  1. The Consolidated Financial Results includes the results for the quarter ended 31st March, 2026 being the balancing figure between the audited figures in respect of the full financial year and the published unaudited year to date figures up to the third quarter of the current financial year which were subject to limited review by us.

Our opinion is not modified in respect of above matter.

For CNK & Associates LLP
Chartered Accountants
Firm Registration No. 101961W/W-100036

img-9.jpeg

Rachit Sheth
Partner
Membership No.158289
Place: Vadodara
Date: 19th May, 2026
UDIN: 26158289EVPKXM2545

img-10.jpeg


Alembic

ALEMBIC LIMITED

CIN:L26100GJ1907PLC000033

Regd. Office: Alembic Road, Vadodara 390 003

Ph:0265 6637000

www.alembiclimited.com Email:[email protected]

Statement of Standalone Audited Financial Results for the Quarter and Year ended 31st March, 2026
Rs. in Lakhs

Sr. No. Particulars Quarter Ended Year Ended
31.3.2026 (Audited) 31.12.2025 (Unaudited) 31.03.2025 (Audited) 31.3.2026 (Audited) 31.03.2025 (Audited)
1 Revenue from Operations 5,773 7,228 5,822 23,193 21,436
2 Other Income 241 210 278 7,277 7,451
3 Total Income 6,014 7,438 6,100 30,470 28,887
4 Expenses
Cost of Materials Consumed 404 385 192 1,388 800
Cost of Construction 1,463 2,238 1,549 6,002 6,005
Changes in Inventories of Finished Goods and WIP (65) 105 (3) 255 111
Employee Benefit Expenses 1,174 1,032 650 3,744 2,731
Finance Costs 37 37 45 157 183
Depreciation and amortisation expense 325 334 266 1,201 1,024
Other Expenses 841 762 832 3,035 2,833
Total Expenses 4,180 4,894 3,532 15,781 13,688
5 Profit Before Tax (3-4) 1,834 2,544 2,568 14,689 15,199
6 Tax Expenses
Current Tax 550 379 315 2,200 1,675
Deferred Tax 301 (61) 126 5 (514)
Short / (Excess) Provision of earlier years 30 - (156) 30 (156)
7 Net Profit after tax for the Period 953 2,226 2,283 12,454 14,195
8 Other Comprehensive Income
(i) Items that will not be reclassified to Profit or (Loss)
(ii) Income tax relating to items that will not be reclassified to Profit or (Loss) (11,668) (13,729) (2,673) (10,363) (3,457)
1,240 1,805 383 898 (132)
9 Total Comprehensive Income/(Loss) for the Period (9,476) (9,698) (7) 2,989 10,606
10 Paid up Equity Share Capital (Face Value of Rs 2/- per share) 5,135.64 5,135.64 5,135.64 5,135.64 5,135.64
11 Other Equity (excluding Revaluation Reserve) 62,564 56,250
12 Earnings per equity share (FV Rs. 2/- per share)
Basic & Diluted (In Rs.) 0.37 0.87 0.89 4.85 5.53

img-11.jpeg

img-12.jpeg


R. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S.

Alembic Limited

Segment wise Standalone Revenue and Results

Rs. in Lakhs

Sr. No. Particulars Quarter Ended Year Ended
31.03.2026
(Audited) 31.12.2025
(Unaudited) 31.03.2025
(Audited) 31.03.2026
(Audited) 31.03.2025
(Audited)
1 Segment Revenue
Revenue from Operations
a. Active Pharmaceutical Ingredients Business 983 1,350 778 4,659 3,221
b. Real Estate Business 4,790 5,878 5,043 18,535 18,214
Total Income from Operations (Net) 5,773 7,228 5,822 23,193 21,436
2 Segment Results (Profit (+)/ Loss (-) before Taxes and interest from each segment)
a. Active Pharmaceutical Ingredients Business (117) 214 188 565 473
b. Real Estate Business 2,067 2,336 2,423 7,859 8,390
Total 1,950 2,550 2,611 8,424 8,863
Unallocable Income and Expenditure
(i) Interest Expense (37) (37) (45) (157) (183)
(ii) Dividend Income and Gain/(Loss) on Fair Value Change of Financial Asset (121) 18 (12) 6,167 6,471
(iii) Other Income / (Expense) 42 14 15 255 47
Total Profit Before Tax 1,834 2,544 2,568 14,689 15,199
3 Segment Assets
a. Active Pharmaceutical Ingredients Business 18,081 18,400 18,722 18,081 18,722
b. Real Estate Business 50,165 47,664 43,080 50,165 43,080
c. Unallocated 27,524 40,056 39,181 27,524 39,181
Total 95,770 1,06,120 1,00,983 95,770 1,00,983
4 Segment Liabilities
a. Active Pharmaceutical Ingredients Business 3,480 3,350 3,128 3,480 3,128
b. Real Estate Business 7,190 7,160 9,022 7,190 9,022
c. Unallocated 2,954 3,988 3,514 2,954 3,514
Total 13,625 14,498 15,664 13,625 15,664

Notes:

  1. The above results have been audited by Statutory Auditors, recommended by Audit Committee and approved by the Board of Directors of the Company.

  2. The Board has recommended Dividend on equity shares at Rs 2.40 per share (face value Rs. 2/- each) i.e 120% for the year ended on 31st March, 2026 (Previous year Rs. 2.40 per share i.e 120%.)

  3. The previous quarter’s / year’s figures have been regrouped / rearranged wherever necessary to make it comparable with the current quarter / year.

  4. The figures for the quarter ended 31st March, 2026 and corresponding quarter ended 31st March, 2025 are the balancing figures between the audited figures in respect of full financial year and year to date figures upto third quarter of the respective financial years which were subject to limited review.

  5. The Government of India has notified the implementation of four new Labour Codes effective 21st November, 2025, by consolidating and rationalizing 29 existing labour laws. The Company has provisionally estimated the financial implications thereof and has made additional provision under ‘Employee Benefit Expense’ for Rs. 143.72 lakh in the financial results for the quarter ended on 31st December, 2025. This will be reviewed and revised, if required once all applicable Rules are notified by the Government on all aspects of the Codes.

Place : Vadodara
Date : 19th May, 2026

img-13.jpeg

For Alembic Limited

img-14.jpeg


R5. In Lakhs

Alembic Limited

Statement of Standalone Assets and Liabilities

Particulars As at 31st March, 2026 (Audited) As at 31st March, 2025 (Audited)
ASSETS
Non-Current Assets
(a) Property, Plant and Equipments 16,995 13,533
(b) Capital Work-in-Progress 150
(c) Investment Property 29,959 27,107
(d) Financial Assets
(i) Investments 25,985 36,411
(ii) Others 497 802
(e) Other Non-Current Assets 3,500 3,500
77,086 81,352
Current Assets
(a) Inventories 5,224 9,939
(b) Financial Assets
(i) Investments 8,905 4,956
(ii) Trade Receivables 3,021 2,789
(iii) Cash and Cash Equivalents 110 253
(iv) Bank Balances other than Cash and Cash Equivalents 187 166
(v) Others 353 319
(c) Other Current Assets 884 1,210
18,685 19,631
TOTAL - ASSETS 95,770 1,00,983
EQUITY AND LIABILITIES
Equity
(a) Equity Share Capital 5,136 5,136
(b) Other Equity 77,010 80,183
82,146 85,319
Liabilities
Non-Current Liabilities
(a) Financial Liabilities
(i) Borrowings 661 1,067
(ii) Other Financial Liabilities 1,021 691
(b) Provisions 372 244
(c) Deferred Tax Liability (Net) 1,941 2,834
3,994 4,836
Current Liabilities
(a) Financial Liabilities
(i) Borrowings 403 378
(ii) Trade Payables
a) total outstanding dues of Micro and Small Enterprises 677 521
b) total outstanding dues of Others 1,619 2,237
(iii) Other Financial Liabilities 800 607
(b) Other Current Liabilities 2,838 4,253
(c) Provisions 2,280 2,152
(d) Current Tax Liabilities (Net) 1,013 680
9,631 10,828
TOTAL - EQUITY AND LIABILITIES 95,770 1,00,983

Place : Vadodara
Date : 19th May, 2026

img-15.jpeg

img-16.jpeg


Alembic Limited

Standalone Statement of Cash Flow for Year ended 31st March, 2026

Rs. In Lakhs

Particulars For the Year Ended on 31st March, 2026 (Audited) For the Year Ended on 31st March, 2025 (Audited)
A CASH FLOW FROM OPERATING ACTIVITIES:
Net Profit before tax 14,689 15,199
Add:
Depreciation 1,201 1,024
Interest charged 157 183
(Gain) / Loss on sale of Property, Plant and Equipments - 105
Other Non cash items 37 (198)
Less:
Interest Income (140) (193)
Dividend Income (6,295) (6,295)
Operating Profit before change in working capital 9,648 9,825
Working capital changes:
Add / (Less) :
(Increase) / Decrease in Inventories 4,715 (678)
(Increase) / Decrease in Trade Receivables (232) (1,049)
(Increase) / Decrease in Other Assets 325 (430)
(Increase) / Decrease in Financial Assets 271 211
Increase / (Decrease) in Trade Payables (463) (283)
Increase / (Decrease) in Financial Liabilities 501 71
Increase / (Decrease) in Other Liabilities (1,415) 1,840
Increase / (Decrease) in Provisions 286 47
Cash generated from operations 13,637 9,554
Add / (Less) :
(Direct taxes paid (Net of refunds) (1,897) (1,451)
Net cash inflow from operating activities (A) 11,740 8,103
B CASH FLOW FROM INVESTING ACTIVITIES:
Add:
Proceeds from sale of Property, Plant and Equipments - 0
Proceeds from sale / redemption of Investments 13,029 11,511
Interest received 140 193
Dividend received 6,295 6,295
Less: 19,464 17,999
Purchase of PPE and Investment Property/Increase in CWIP and Capital Advances 7,665 5,077
Purchase of Investments 16,982 15,056
Increase in Restricted Bank Balances other than Cash & Cash Equivalents 21 45
24,668 20,178
Net cash inflow from Investing activities (B) (5,204) (2,179)
C CASH FLOW FROM FINANCING ACTIVITIES:
Add:
Proceeds from long term borrowings - 530
Less:
Dividends paid 6,141 6,117
Interest and other finance costs 157 183
Repayment of borrowings 591 -
6,679 6,300
Net cash inflow from Financing activities (C) (6,679) (5,770)
I. Net (Decrease) / Increase in cash and cash equivalents (A+B+C) (143) 154
II. Cash and cash equivalents at the beginning of the period 253 99
III. Cash and cash equivalents at the end of the period (I+II) 110 253
IV. Cash and cash equivalents at the end of the period
Balances with Bank 110 252
Cash on Hand 0 1
Cash and cash equivalents 110 253

Place : Vadodara

Date : 19th May, 2026

VADODARA

Ansgar Alabac

Ansgar Alabac

For Alembic Limited

Chirayu Amin

Chairman


CNK & Associates LLP
Chartered Accountants

Independent Auditor's Report on Audited Standalone Quarterly Financial Results and Year to Date Results of the Alembic Limited Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended

TO THE BOARD OF DIRECTORS OF ALEMBIC LIMITED

Report on the audit of the Standalone Financial Results

Opinion

We have audited the accompanying statement of standalone financial results of Alembic Limited (the Company) for quarter and year ended 31st March, 2026 (the “Statement”), attached herewith, being submitted by the Company pursuant to the requirement of Regulation 33 of the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“Listing Regulations”).

In our opinion and to the best of our information and according to the explanations given to us, these standalone financial results:

i. are presented in accordance with the requirements of Regulation 33 of the Listing Regulations in this regard; and
ii. Give a true and fair view in conformity with the recognition and measurement principles laid down in the applicable Indian accounting standards (“Ind AS”) and other accounting principles generally accepted in India, of the net profit and other comprehensive income and other financial information for the quarter and year ended 31st March, 2026.

Basis of Opinion

We conducted our audit in accordance with the Standards on Auditing (“SAs”) specified under section 143(10) of the Companies Act, 2013, as amended (“the Act”). Our responsibilities under those Standards are further described in the “Auditor’s Responsibilities for the Audit of the Standalone Financial Results” section of our report. We are independent of the Company, in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the standalone financial results under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

The Nirat, 3rd Floor, 18, Winward Business Park, Behind Emerald One Complex, In the lane of the Prasant Burek Hospital, Jetalpur, Vadodara 390 007. Tel: +91 265 234 3483

Website: www.cnkindia.com

VADODARA | MUMBAI | CHENNAI | AHMEDABAD | GIFT CITY | GURGOON | KOLKATA | BENGALURU | DELHI | PUNE | DUBAI | ABU DHABI


Emphasis of Matter

We draw attention to the status of disputed liability related to pending electricity duty matter. During the previous periods, the Company had made aggregate provision towards total principal amount being Rs. 2,052.13 lakhs for the disputed matter(s) filed against State of Gujarat, Collector of Electricity Duty & others. The interest amount thereon is not ascertainable and is disclosed as contingent liability in the Standalone Financial Statements for the year ended 31st March, 2026. Further, the Company has deposited Rs. 3,500.00 lakhs with the Hon’ble Supreme Court on 26th May, 2023 and the appeal filed by the Company has been admitted.

Our opinion is not modified in respect of above matter.

Management’s and Board of Directors’ Responsibilities for the Standalone Financial Results

These standalone financial results have been prepared on the basis of the standalone annual financial statements. The Company’s Management and Board of Directors are responsible for the preparation and presentation of these standalone financial results that give a true and fair view of the net profit and other comprehensive income and other financial information in accordance with the recognition and measurement principles laid down in Indian Accounting Standards prescribed under Section 133 of the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the standalone financial results that give a true and fair view and are free from material misstatement, whether due to fraud or error.

In preparing the standalone financial results, the Management and Board of Directors are responsible for assessing the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

The Board of Directors are also responsible for overseeing the Company’s financial reporting process.

VADODARA


Auditor's Responsibilities for the Audit of the Standalone Financial Results

Our objectives are to obtain reasonable assurance about whether the standalone financial results as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these standalone financial results.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

  • Identify and assess the risks of material misstatement of the standalone financial results, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

  • Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under Section 143(3) (i) of the Act, we are also responsible for expressing our opinion through a separate report on the complete set of financial statements on whether the company has adequate internal financial controls with reference to standalone financial statements in place and the operating effectiveness of such controls.

  • Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the Management and the Board of directors in term of requirement specified under Regulation 33 of the listing Regulations;

  • Conclude on the appropriateness of the Management and the Board of Directors’ use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in

SANTA ANASOCATY 1500 AYRACI


our auditor's report to the related disclosures in the standalone financial results or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.

  • Evaluate the overall presentation, structure and content of the standalone financial results, including the disclosures, and whether the standalone financial results represent the underlying transactions and events in a manner that achieves fair presentation.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

Other matter

The Statement includes the results for the quarter ended 31st March, 2026 being the balancing figures between the audited figures in respect of full financial year ended 31st March, 2026 and the published unaudited year to date figures up to the third quarter of the current financial year, which were subjected to a limited review by us, as required under the Listing Regulations.

Our opinion is not modified in respect of above matter.

For CNK & Associates LLP
Chartered Accountants
Firm Registration No. 101961W/W-100036

img-17.jpeg

Rachit Sheth
Partner
Membership No.158289
Place: Vadodara
Date: 19th May, 2026
UDIN: 26158289HFDATT9890